aromadedrin has been researched along with datiscetin in 2 studies
| Studies (aromadedrin) | Trials (aromadedrin) | Recent Studies (post-2010) (aromadedrin) | Studies (datiscetin) | Trials (datiscetin) | Recent Studies (post-2010) (datiscetin) |
|---|---|---|---|---|---|
| 89 | 0 | 54 | 12 | 0 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, K; Irie, K; Katayama, S; Masuda, Y; Murakami, K; Nakagawa, Y; Sato, M; Takegoshi, K; Uno, M | 1 |
| Busquets, MA; Espargaró, A; Estelrich, J; Ginex, T; Luque, FJ; Muñoz-Torrero, D; Sabate, R; Vadell, MD | 1 |
2 other study(ies) available for aromadedrin and datiscetin
| Article | Year |
|---|---|
Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Catechols; Humans; Lysine; Norleucine; Peptide Fragments; Quercetin | 2013 |
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Apigenin; Benzaldehydes; Cinnamates; Depsides; Flavonoids; Humans; In Vitro Techniques; Molecular Structure; Peptide Fragments; Phenols; Quercetin; Rosmarinic Acid | 2017 |